PKM and glioblastoma: The pyruvate kinase M2 isoform (PKM2) phosphorylates Bcl2 and directly inhibits apoptosis, demonstrating that the HSP90-PKM2-Bcl2 axis is a potential target for therapeutic intervention in GBM (22).